Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Puddu, Alessandra ^a   Sanguineti, Roberta ^a   Montecucco, Fabrizio ^a,b   Viviani, Giorgio L ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOKINASE; GLUCOSE; GLYCATED SERUM GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PROGLUCAGON; PROPROTEIN CONVERTASE 1; REACTIVE OXYGEN METABOLITE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN 1; UNCLASSIFIED DRUG; SNAP25 PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DILUTION; DOWN REGULATION; ENZYME INDUCTION; GENE EXPRESSION; HORMONE RELEASE; IN VITRO STUDY; INSULIN SENSITIVITY; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; UPREGULATION; BLOOD; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; METABOLISM;

BLOOD GLUCOSE; CELL LINE; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; GLUCOKINASE; HUMANS; INFLAMMATION; INSULIN; PROGLUCAGON; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; SYNTAXIN 1;

EID: 84896819908     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/923120     Document Type: Article

References (48)

1. Drucker D. J., Philippe J., Mojsov S., Chick W. L., Habener J. F., Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proceedings of the National Academy of Sciences of the United States of America 1987 84 10 3434 3438 2-s2.0-0344357096 (Pubitemid 17085418)
2. Drucker D. J., Nauck M. A., The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet 2006 368 9548 1696 1705 2-s2.0-33846006173 10.1016/S0140-6736(06)69705-5 (Pubitemid 46048557)
3. Holst J. J., The physiology of glucagon-like peptide 1. Physiological Reviews 2007 87 4 1409 1439 2-s2.0-35748957503 10.1152/physrev.00034.2006 (Pubitemid 350041474)
4. Elliott R. M., Morgan L. M., Tredger J. A., Deacon S., Wright J., Marks V., Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. Journal of Endocrinology 1993 138 1 159 166 2-s2.0-0027227370 (Pubitemid 23266831)
5. Herrmann C., Goke R., Richter G., Fehmann H.-C., Arnold R., Goke B., Glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide plasma levels in response to nutrients. Digestion 1995 56 2 117 126 2-s2.0-0028838030
6. Toft-Nielsen M.-B., Damholt M. B., Madsbad S., Hilsted L. M., Hughes T. E., Michelsen B. K., Holst J. J., Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism 2001 86 8 3717 3723 2-s2.0-0034880655 10.1210/jc.86.8.3717 (Pubitemid 32755966)
7. Vollmer K., Hoist J. J., Bailer B., Ellrlchmann M., Nauck M. A., Schmidt W. E., Meier J. J., Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008 57 3 678 687 2-s2.0-40949090627 10.2337/db07-1124
8. Orskov C., Jeppesen J., Madsbad S., Holst J. J., Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. Journal of Clinical Investigation 1991 87 2 415 423 2-s2.0-0026027919
9. Fernandez-Garcia J. C., Murri M., Coin-Araguez L., Alcaide J., El Bekay R., Tinahones F. J., GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects. Clinical Endocrinology 2013 10.1111/cen.12221
10. Nauck M. A., Vardarli I., Deacon C. F., Holst J. J., Meier J. J., Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011 54 1 10 18 2-s2.0-79952310049 10.1007/s00125-010-1896-4
11. Rask E., Olsson T., Söderberg S., Johnson O., Seckl J., Holst J. J., Ahrén B., Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 2001 24 9 1640 1645 2-s2.0-0035462466 (Pubitemid 33716463)
12. Rask E., Olsson T., Söderberg S., Holst J. J., Tura A., Pacini G., Ahrén B., Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism 2004 53 5 624 631 2-s2.0-2342642148 10.1016/j.metabol.2003.11.011 (Pubitemid 38596536)
13. Lim G. E., Huang G. J., Flora N., Leroith D., Rhodes C. J., Brubaker P. L., Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. Endocrinology 2009 150 2 580 591 2-s2.0-59649088932 10.1210/en.2008-0726
14. Ceriello A., Ihnat M. A., Thorpe J. E., The "Metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? Journal of Clinical Endocrinology and Metabolism 2009 94 2 410 415 2-s2.0-59749094860 10.1210/jc.2008-1824
15. Drzewoski J., Kasznicki J., Trojanowski Z., The role of "metabolic memory" in the natural history of diabetes mellitus. Polskie Archiwum Medycyny Wewnetrznej 2009 119 7-8 493 500 2-s2.0-69249138364
16. Roy S., Sala R., Cagliero E., Lorenzi M., Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proceedings of the National Academy of Sciences of the United States of America 1990 87 1 404 408 2-s2.0-0025067393 10.1073/pnas.87.1.404 (Pubitemid 20033079)
17. Singh R., Barden A., Mori T., Beilin L., Advanced glycation end-products: a review. Diabetologia 2001 44 2 129 146 2-s2.0-0035135246 10.1007/ s001250051591 (Pubitemid 32156196)
18. Puddu A., Sanguineti R., Durante A., Nencioni A., Mach F., Montecucco F., Viviani G. L., Glucagon-like Peptide-1 triggers protective pathways in pancreatic Beta-cells exposed to glycated serum. Mediators of Inflammation 2013 2013 10 317120 10.1155/2013/317120
19. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615 (Pubitemid 40770750)
20. Beisswenger P. J., Makita Z., Curphey T. J., Moore L. L., Jean S., Brinck-Johnsen T., Bucala R., Vlassara H., Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 1995 44 7 824 829 2-s2.0-0029118168
21. Genuth S., Sun W., Cleary P., Sell D. R., Dahms W., Malone J., Sivitz W., Monnier V. M., Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 2005 54 11 3103 3111 2-s2.0-33644698951 10.2337/diabetes.54.11.3103 (Pubitemid 43334362)
22. Meerwaldt R., Links T. P., Graaff R., Hoogenberg K., Lefrandt J. D., Baynes J. W., Gans R. O. B., Smit A. J., Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005 48 8 1637 1644 2-s2.0-23844441894 10.1007/s00125-005-1828-x (Pubitemid 41175518)
23. Ihnat M. A., Thorpe J. E., Kamat C. D., Szabó C., Green D. E., Warnke L. A., Lacza Z., Cselenyák A., Ross K., Shakir S., Piconi L., Kaltreider R. C., Ceriello A., Reactive oxygen species mediate a cellular "memory" of high glucose stress signalling. Diabetologia 2007 50 7 1523 1531 2-s2.0-34249934468 10.1007/s00125-007-0684-2 (Pubitemid 46879013)
24. Ceriello A., The emerging challenge in diabetes: the, 'metabolic memory'. Vascular Pharmacology 2012 57 133 138 10.1016/j.vph.2012.05.005
25. Zhang L., Chen B., Tang L., Metabolic memory: mechanisms and implications for diabetic retinopathy. Diabetes Research and Clinical Practice 2012 96 286 293 10.1016/j.diabres.2011.12.006
26. Drucker D. J., Jin T., Asa S. L., Young T. A., Brubaker P. L., Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Molecular Endocrinology 1994 8 12 1646 1655 2-s2.0-0028575660
27. Luciano Viviani G., Puddu A., Sacchi G., Garuti A., Storace D., Durante A., Monacelli F., Odetti P., Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro. Metabolism 2008 57 2 163 169 2-s2.0-38049144209 10.1016/j.metabol.2007.08.020
28. Odetti P., Fogarty J., Sell D. R., Monnier V. M., Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992 41 2 153 159 2-s2.0-0026501919
29. Sugiyama S., Miyata T., Ueda Y., Tanaka H., Maeda K., Kawashima S., Van Ypersele De Strihou C., Kurokawa K., Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. Journal of the American Society of Nephrology 1998 9 9 1681 1688 2-s2.0-0031752572
30. Kappe C., Holst J. J., Zhang Q., Sjoholm A., Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells. Biochemical and Biophysical Research Communications 2012 427 91 95 10.1016/j.bbrc.2012.09.010
31. Goldin A., Beckman J. A., Schmidt A. M., Creager M. A., Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006 114 6 597 605 2-s2.0-33746920337 10.1161/CIRCULATIONAHA.106. 621854 (Pubitemid 44199649)
32. Niiya Y., Abumiya T., Yamagishi S.-I., Takino J.-I., Takeuchi M., Advanced glycation end products increase permeability of brain microvascular endothelial cells through reactive oxygen species-induced vascular endothelial growth factor expression. Journal of Stroke and Cerebrovascular Diseases 2012 21 4 293 298 2-s2.0-84860124109 10.1016/j.jstrokecerebrovasdis.2010.09.002
33. Kieffer T. J., Habener J. F., The glucagon-like peptides. Endocrine Reviews 1999 20 6 876 913 2-s2.0-0033304603 (Pubitemid 30647076)
34. Dhanvantari S., Izzo A., Jansen E., Brubaker P. L., Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells. Endocrinology 2001 142 1 37 42 2-s2.0-0035114987 10.1210/en.142.1.37 (Pubitemid 32183663)
35. Némoz-Gaillard E., Bosshard A., Regazzi R., Bernard C., Cuber J.-C., Takahashi M., Catsicas S., Chayvialle J.-A., Abello J., Expression of SNARE proteins in enteroendocrine cell lines and functional role of tetanus toxin-sensitive proteins in cholecystokinin release. FEBS Letters 1998 425 1 66 70 2-s2.0-0032549616 10.1016/S0014-5793(98)00209-9 (Pubitemid 28149742)
36. Unoki H., Bujo H., Yamagishi S.-I., Takeuchi M., Imaizumi T., Saito Y., Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Research and Clinical Practice 2007 76 2 236 244 2-s2.0-33947115243 10.1016/j.diabres.2006.09.016 (Pubitemid 46400134)
37. Unoki H., Yamagishi S.-I., Advanced glycation end products and insulin resistance. Current Pharmaceutical Design 2008 14 10 987 989 2-s2.0-44449114217 10.2174/138161208784139747 (Pubitemid 351753287)
38. Miele C., Riboulet A., Maitan M. A., Oriente F., Romano C., Formisano P., Giudicelli J., Beguinot F., Van Obberghen E., Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism. Journal of Biological Chemistry 2003 278 48 47376 47387 2-s2.0-0346850870 10.1074/jbc.M301088200 (Pubitemid 37523177)
39. Cassese A., Esposito I., Fiory F., Barbagallo A. P. M., Paturzo F., Mirra P., Ulianich L., Giacco F., Iadicicco C., Lombardi A., Oriente F., Van Obberghen E., Beguinot F., Formisano P., Miele C., In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. Journal of Biological Chemistry 2008 283 52 36088 36099 2-s2.0-61349095437 10.1074/jbc.M801698200
40. Kohnert K. D., Freyse E. J., Salzsieder E., Glycaemic variability and pancreatic beta-cell dysfunction. Current Diabetes Reviews 2012 8 345 354 10.2174/157339912802083513
41. Gustavsson N., Han W., Calcium-sensing beyond neurotransmitters: functions of synaptotagmins in neuroendocrine and endocrine secretion. Bioscience Reports 2009 29 4 245 259 2-s2.0-70349560095 10.1042/BSR20090031
42. Reimann F., Gribble F. M., Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 2002 51 9 2757 2763 2-s2.0-0036724256 (Pubitemid 34970929)
43. Tolhurst G., Reimann F., Gribble F. M., Nutritional regulation of glucagon-like peptide-1 secretion. Journal of Physiology 2009 587 1 27 32 2-s2.0-58149295120 10.1113/jphysiol.2008.164012
44. Ohara-Imaizumi M., Aoyagi K., Akimoto Y., Nakamichi Y., Nishiwaki C., Kawakami H., Nagamatsu S., Imaging exocytosis of single glucagon-like peptide-1 containing granules in a murine enteroendocrine cell line with total internal reflection fluorescent microscopy. Biochemical and Biophysical Research Communications 2009 390 1 16 20 2-s2.0-70349954766 10.1016/j.bbrc.2009.09.043
45. Somanath S., Barg S., Marshall C., Silwood C. J., Turner M. D., High extracellular glucose inhibits exocytosis through disruption of syntaxin 1A-containing lipid rafts. Biochemical and Biophysical Research Communications 2009 389 2 241 246 2-s2.0-70349325497 10.1016/j.bbrc.2009.08.126
46. Gaspar J. M., Castilho Á., Baptista F. I., Liberal J., Ambrósio A. F., Long-term exposure to high glucose induces changes in the content and distribution of some exocytotic proteins in cultured hippocampal neurons. Neuroscience 2010 171 4 981 992 2-s2.0-78650169655 10.1016/j. neuroscience.2010.10.019
47. Puddu A., Durante A., Poggi A., Odetti P., Viviani G. L., Glycated serum decreases insulin content and modifies the expression of proteins involved in insulin granule exocytosis. Diabetes 2005 54 A653
48. Thurmond D. C., Insulin-regulated glucagon-like peptide-1 release from l cells: actin' out. Endocrinology 2009 150 12 5202 5204 2-s2.0-71949088021 10.1210/en.2009-1178